By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Viral vaccines > Abrysvo > Abrysvo Dosage
Viral vaccines
https://themeditary.com/dosage-information/abrysvo-dosage-4612.html

Abrysvo Dosage

Drug Detail:Abrysvo (Respiratory syncytial virus vaccine)

Generic Name: RECOMBINANT STABILIZED RSV A PREFUSION F ANTIGEN 0.06mg in 0.5mL, RECOMBINANT STABILIZED RSV B PREFUSION F ANTIGEN 0.06mg in 0.5mL;

Drug Class: Viral vaccines

Contents
Uses Warnings Before Taking Dosage Side effects Interactions

Dose and Schedule

Administer a single dose (approximately 0.5 mL) of ABRYSVO intramuscularly.

Preparation for Administration

ABRYSVO is supplied in a kit that includes a vial of Lyophilized Antigen Component (a sterile white powder), a prefilled syringe containing Sterile Water Diluent Component and a vial adapter.

Vial of Lyophilized Antigen Component

Syringe of Sterile Water Diluent Component

Vial Adapter

Vial Syringe Vial adapter

To form ABRYSVO, reconstitute the Lyophilized Antigen Component with the accompanying Sterile Water Diluent Component as described in the panels below.

Step 1

Step 1. Preparation of vial and vial adapter

•
Remove plastic flip off cap from vial and cleanse the rubber stopper.
•
Without removing the vial adapter from its packaging, peel off the top cover.
Step 2

Step 2. Attachment of vial adapter

•
Hold the base of the vial on a flat surface.
•
Keep the vial adapter in the packaging and orient it vertically over the center of the vial so that the adapter spike aligns with the center of the vial’s rubber stopper.
•
Connect the vial adapter to the vial with a straight downward push. The vial adapter will lock into place.
•
Do not push vial adapter in at an angle as this may result in leaking during use.
•
Remove the vial adapter packaging.
Step 3

Step 3. Removal of syringe cap

•
For all syringe assembly steps, hold the syringe only by the Luer lock adapter located at the tip of the syringe. This will prevent the Luer lock adapter from detaching during use.
•
Remove the syringe cap by slowly turning the cap counter-clockwise while holding the Luer lock adapter.
Step 4

Step 4. Connection of syringe to vial adapter

•
Hold the syringe’s Luer lock adapter and connect it to the vial adapter by turning clockwise.
•
Stop turning when you feel resistance, overtightening the syringe may result in leaking during use.
•
Once the syringe is securely attached to the vial adapter, there will be a small space between the top of the vial adapter and the Luer lock adapter of the syringe.
Step 5

Step 5. Reconstitution of Lyophilized Antigen Component to form ABRYSVO

•
Inject the entire contents of the syringe containing the Sterile Water Diluent Component into the vial.
•
Do not remove the empty syringe.
•
While holding the plunger rod down, gently swirl the vial in a circular motion until the powder is completely dissolved (less than 1 minute).
•
Do not shake.
Step 6

Step 6. Withdrawal of reconstituted vaccine

•
Invert the vial completely with the vial adapter and syringe still attached.
•
Slowly withdraw the entire contents into the syringe to ensure an approximately 0.5 mL dose of ABRYSVO for administration.
•
Do not pull the plunger rod out.
Step 7

Step 7. Disconnection of syringe

•
Hold the Luer lock adapter of the syringe and disconnect the syringe from the vial adapter by turning counter-clockwise.
Step 8

Step 8. Attachment of needle

•
Attach a sterile needle suitable for intramuscular injection to the syringe containing ABRYSVO.
Step 9

Step 9. Visual inspection

•
ABRYSVO is a clear and colorless solution.
•
Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Discard if either condition is present.

Administration

For intramuscular injection only

After reconstitution, administer ABRYSVO immediately or store at room temperature [15°C to 30°C (59°F to 86°F)] and use within 4 hours. Discard reconstituted vaccine if not used within 4 hours.

Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by